These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 34726055)

  • 1. A Perspective on Medicinal Chemistry Approaches for Targeting Pyruvate Kinase M2.
    Arora S; Joshi G; Chaturvedi A; Heuser M; Patil S; Kumar R
    J Med Chem; 2022 Jan; 65(2):1171-1205. PubMed ID: 34726055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical and structural insights into how amino acids regulate pyruvate kinase muscle isoform 2.
    Nandi S; Dey M
    J Biol Chem; 2020 Apr; 295(16):5390-5403. PubMed ID: 32144209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyruvate kinase M2: A simple molecule with complex functions.
    Alquraishi M; Puckett DL; Alani DS; Humidat AS; Frankel VD; Donohoe DR; Whelan J; Bettaieb A
    Free Radic Biol Med; 2019 Nov; 143():176-192. PubMed ID: 31401304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cysteine residue at 424th of pyruvate kinase M2 is crucial for tetramerization and responsiveness to oxidative stress.
    Masaki S; Hashimoto K; Kihara D; Tsuzuki C; Kataoka N; Suzuki K
    Biochem Biophys Res Commun; 2020 Jun; 526(4):973-977. PubMed ID: 32295714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of PKM2 in Metabolic Reprogramming: Insights into the Regulatory Roles of Non-Coding RNAs.
    Puckett DL; Alquraishi M; Chowanadisai W; Bettaieb A
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33503959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PKM2-dependent glycolysis promotes the proliferation and migration of vascular smooth muscle cells during atherosclerosis.
    Zhao X; Tan F; Cao X; Cao Z; Li B; Shen Z; Tian Y
    Acta Biochim Biophys Sin (Shanghai); 2020 Jan; 52(1):9-17. PubMed ID: 31867609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycolytic reprogramming in cancer cells: PKM2 dimer predominance induced by pulsatile PFK-1 activity.
    Shi X; You L; Luo RY
    Phys Biol; 2019 Sep; 16(6):066007. PubMed ID: 31469100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis for allosteric regulation of pyruvate kinase M2 by phosphorylation and acetylation.
    Nandi S; Razzaghi M; Srivastava D; Dey M
    J Biol Chem; 2020 Dec; 295(51):17425-17440. PubMed ID: 33453989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allosteric regulation of PKM2 allows cellular adaptation to different physiological states.
    Gui DY; Lewis CA; Vander Heiden MG
    Sci Signal; 2013 Feb; 6(263):pe7. PubMed ID: 23423437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyruvate kinase modulators as a therapy target: an updated patent review 2018-2023.
    Adem S; Rasul A; Riaz S; Sadiqa A; Ahmad M; Shahid Nazir M; Hassan M
    Expert Opin Ther Pat; 2024 Oct; 34(10):953-962. PubMed ID: 39279560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor M2-PK: A novel urine marker of bladder cancer.
    Liu W; Woolbright BL; Pirani K; Didde R; Abbott E; Kaushik G; Martin P; Hamilton-Reeves J; Taylor JA; Holzbeierlein JM; Anant S; Lee EK
    PLoS One; 2019; 14(6):e0218737. PubMed ID: 31246990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin K(3) and K(5) are inhibitors of tumor pyruvate kinase M2.
    Chen J; Jiang Z; Wang B; Wang Y; Hu X
    Cancer Lett; 2012 Mar; 316(2):204-10. PubMed ID: 22154083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of boronic acid-based potent activators of tumor pyruvate kinase M2 and development of gastroretentive nanoformulation for oral dosing.
    Patle R; Shinde S; Patel S; Maheshwari R; Jariyal H; Srivastava A; Chauhan N; Globisch C; Jain A; Tekade RK; Shard A
    Bioorg Med Chem Lett; 2021 Jun; 42():128062. PubMed ID: 33901643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanistic and Structural Insights into Cysteine-Mediated Inhibition of Pyruvate Kinase Muscle Isoform 2.
    Srivastava D; Nandi S; Dey M
    Biochemistry; 2019 Sep; 58(35):3669-3682. PubMed ID: 31386812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of novel sulfonamide derivatives containing pyridin-3-ylmethyl 4-(benzoyl)piperazine-1-carbodithioate moiety as potent PKM2 activators.
    Li R; Ning X; He J; Lin Z; Su Y; Li R; Yin Y
    Bioorg Chem; 2021 Mar; 108():104653. PubMed ID: 33517002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benserazide is a novel inhibitor targeting PKM2 for melanoma treatment.
    Zhou Y; Huang Z; Su J; Li J; Zhao S; Wu L; Zhang J; He Y; Zhang G; Tao J; Zhou J; Chen X; Peng C
    Int J Cancer; 2020 Jul; 147(1):139-151. PubMed ID: 31652354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyruvate Kinase M2 Contributes to TLR-Mediated Inflammation and Autoimmunity by Promoting Pyk2 Activation.
    Zhang X; Yang Y; Jing L; Zhai W; Zhang H; Ma Q; Li C; Yan F; Cheng D; Zhang J; Ning Z; Shi H; Wang C; Zhao M; Dai J; Li Z; Ming J; Yu M; Wang H; Cheng H; Xiong H; Dong G
    Front Immunol; 2021; 12():680068. PubMed ID: 34025679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated In Silico-In Vitro Discovery of Lung Cancer-related Tumor Pyruvate Kinase M2 (PKM2) Inhibitors.
    Ye X; Sun Y; Xu Y; Chen Z; Lu S
    Med Chem; 2016; 12(7):613-620. PubMed ID: 26951145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging roles of PKM2 in cell metabolism and cancer progression.
    Luo W; Semenza GL
    Trends Endocrinol Metab; 2012 Nov; 23(11):560-6. PubMed ID: 22824010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Posttranslational modification of pyruvate kinase type M2 (PKM2): novel regulation of its biological roles to be further discovered.
    Zheng S; Liu Q; Liu T; Lu X
    J Physiol Biochem; 2021 Aug; 77(3):355-363. PubMed ID: 33835423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.